Colorectal cancer screening is a set of tests designed to find cancer or precancerous growths in the colon and rectum before symptoms appear. Current guidelines recommend that adults at average risk begin screening at age 45 and continue through age 75. Several types of tests are available, ranging from simple at-home stool samples to full visual exams of the colon, and the best screening test is whichever one you’ll actually do on schedule.
Who Should Be Screened and When
If you have no personal history of colorectal cancer, inflammatory bowel disease, or a hereditary cancer syndrome, and no family history of the disease, you’re considered average risk. For average-risk adults, screening starts at age 45.
If you have a first-degree relative (a parent, sibling, or child) who was diagnosed with colorectal cancer, especially before age 50, you’re considered higher risk. In that case, screening should start 10 years before the age your relative was diagnosed, or at age 40, whichever comes first. People with hereditary syndromes like Lynch syndrome or familial polyposis often need to begin even earlier, with a schedule set by their care team.
Between ages 76 and 85, screening becomes a more individual decision based on your overall health, life expectancy, and whether you’ve been screened consistently in the past. The net benefit of screening everyone in this age group is small. After age 85, screening is generally no longer recommended.
Stool-Based Tests
Stool-based tests are the least invasive option. You collect a sample at home and mail it to a lab, with no bowel prep, sedation, or time off work required.
The fecal immunochemical test (FIT) is the most widely recommended stool test. It detects tiny amounts of blood in stool that aren’t visible to the naked eye, which can signal polyps or cancer. FIT is done once a year with a single sample. One of its practical advantages is that you don’t need to change your diet or stop any medications before collecting the sample. For detecting colorectal cancer, FIT has a sensitivity of roughly 73% to 88% with a specificity of 90% to 96%, meaning it catches most cancers while producing relatively few false alarms.
An older version called the guaiac-based fecal occult blood test (gFOBT) works on a similar principle but is less accurate and requires three separate stool samples along with dietary restrictions. FIT has largely replaced it because it’s more sensitive, more specific, and easier to complete.
The multi-target stool DNA test (sold as Cologuard) goes a step further. In addition to checking for blood, it analyzes your stool for specific DNA changes associated with cancerous or precancerous cells. It catches colorectal cancer about 92% of the time, which is higher than FIT alone, but it also produces more false positives (its specificity is around 84%). This test is done every three years rather than annually.
What Happens After a Positive Stool Test
A positive result on any stool-based test does not mean you have cancer. It means something was detected that needs a closer look. The follow-up is always a colonoscopy. This is an important detail to understand before choosing a stool test: you’re not avoiding a colonoscopy entirely, you’re potentially delaying one unless something turns up.
Colonoscopy and Sigmoidoscopy
A colonoscopy is the most thorough screening method. A flexible camera examines the entire length of the colon, and if the doctor spots any polyps, they can remove them during the same procedure. This dual ability to detect and remove precancerous growths is what sets colonoscopy apart. For polyps 10 mm or larger, colonoscopy has a sensitivity between 89% and 98%. If the results are normal, most people don’t need another for 10 years.
The tradeoff is preparation. About a week before, you’ll switch to a low-fiber diet and stop certain medications (notably GLP-1 drugs like semaglutide, which need to be paused at least seven days out). The day before, you shift to clear liquids only: water, broth, plain gelatin, clear sports drinks, and coffee or tea without creamer. Nothing red or purple. That evening you begin drinking a large-volume laxative solution, eight ounces every 10 minutes over several hours. The second half is finished the morning of the procedure. By the end, your stool should be clear yellow. The procedure itself uses sedation, so you’ll need someone to drive you home, and most people take the day off.
Flexible sigmoidoscopy is a shorter version that only examines the lower third of the colon. It reduces cancer incidence and death in the lower colon and rectum but misses growths higher up. Colonoscopy covers both the upper and lower colon, which is why it has largely become the preferred visual exam. Sigmoidoscopy also involves less extensive bowel prep and typically doesn’t require sedation.
CT Colonography
Sometimes called a virtual colonoscopy, CT colonography uses a CT scanner to create detailed images of the colon without inserting a scope. It still requires full bowel prep, and if any polyps are found, you’ll need a standard colonoscopy to have them removed. It’s recommended every five years and is most useful for people who can’t undergo sedation or who have anatomical reasons that make traditional colonoscopy difficult.
Blood-Based Screening
In 2024, the FDA approved the first blood test for primary colorectal cancer screening in average-risk adults. Called Shield, it detects specific changes in cell-free DNA floating in the bloodstream that can indicate the presence of a tumor or precancerous growth in the colon. A simple blood draw is obviously the most convenient option, but this test is new and its sensitivity for precancerous polyps is lower than stool-based tests or colonoscopy. As with stool tests, a positive result requires a follow-up colonoscopy.
Screening vs. Diagnostic Colonoscopy
This distinction matters more than most people realize, mainly because of how insurance handles the bill. A screening colonoscopy is one performed on a person with no symptoms and no prior history of polyps, colorectal cancer, or inflammatory bowel disease. Under the Affordable Care Act, preventive screening colonoscopies are covered with no out-of-pocket cost for most insured adults.
A diagnostic colonoscopy is performed because you have symptoms (bleeding, changes in bowel habits, unexplained weight loss) or a personal history of polyps or gastrointestinal disease. Diagnostic procedures are typically subject to copays, deductibles, and coinsurance. If you schedule a routine screening but your provider bills it as diagnostic, you may end up with unexpected costs. In that situation, contact the provider’s office to ask whether the claim can be resubmitted with the correct preventive coding.
Comparing Your Options at a Glance
- FIT: At-home stool sample, once a year, no dietary restrictions, good accuracy for cancer
- Multi-target stool DNA (Cologuard): At-home stool sample, every 3 years, highest stool-test sensitivity for cancer but more false positives
- Colonoscopy: In-person procedure with sedation and full bowel prep, every 10 years if normal, can remove polyps on the spot
- CT colonography: Imaging scan with bowel prep but no sedation, every 5 years, requires colonoscopy follow-up if polyps are found
- Blood test (Shield): Simple blood draw, newest option, lower sensitivity for precancerous growths
The choice often comes down to your comfort with preparation, how you feel about annual testing versus a single procedure every decade, and whether you’d rather catch a problem during the same visit it’s found (colonoscopy) or use a less invasive test that may lead to a colonoscopy later. Any of these tests, done consistently on schedule, is far better than no screening at all. Colorectal cancer caught early, before it spreads beyond the colon wall, has a dramatically better prognosis than cancer found after symptoms appear.